Related Experiment Videos
Time-resolved fluorometry based sandwich hybridisation assay for HLA-DQA1 typing
M Sjöroos1, J Ilonen, H Reijonen
1Department of Biotechnology, University of Turku, Finland. minna.sjoroos@utu.fi
Disease Markers
|August 26, 1998
Summary
A new time-resolved fluorescence (TRF) hybridisation assay was developed for human leukocyte antigen (HLA) typing. This assay accurately detects specific HLA-DQA1 alleles from genomic DNA and whole blood samples.
Area of Science:
- Immunogenetics
- Molecular Biology
- Biochemistry
Background:
- Accurate human leukocyte antigen (HLA) typing is crucial for organ transplantation and disease association studies.
- Existing HLA typing methods can be complex and time-consuming.
- Development of rapid and reliable HLA typing assays is an ongoing need.
Purpose of the Study:
- To develop a novel time-resolved fluorescence (TRF) hybridisation assay for HLA typing.
- To evaluate the assay's performance for specific HLA-DQA1 allele detection.
- To assess the applicability of the assay using both isolated genomic DNA and whole blood samples.
Main Methods:
- Development of a microtitration plate-based TRF hybridisation assay.
- Utilisation of biotinylated sequence-specific catching probes and europium (Eu)-labelled detection probes.
- Amplification of polymorphic exon 2 of the DQA1 gene followed by hybridisation assay.
- Detection of specific hybridisation signals using a time-resolved fluorometer.
Main Results:
- The assay successfully detected targeted DQA1 alleles in 100 isolated genomic DNA samples.
- Specific probes were designed for various DQA1 alleles including *01, *0101/0104, *0103/0201/0601, *0201, *03, *0401/0601, *05, and *0502.
- The assay demonstrated applicability and confirmed results when tested with whole blood spot samples.
Conclusions:
- The developed TRF hybridisation assay provides a sensitive and specific method for HLA typing.
- The assay is capable of detecting specific HLA-DQA1 alleles with high accuracy.
- This method offers a viable alternative for HLA typing using both DNA and blood samples.